NanoViricides Inc (NNVC) Dividend History

$1.35 $0.01

Dividend Score
Dividend Yield

Annual Payment

Payout Ratio
Dividend Increases
0 yrs

Price Chart

Key Metrics

Sector Healthcare
Industry Biotechnology
Avg daily volume 19,689
Market cap 15,632,400
Beta 1.17
Trailing 12 Month EPS -0.62
Next Earnings Date
Ex-dividend date
P/E ratio 0

Company Description

NanoViricides, Inc., a nano-biopharmaceutical research and development company, discovers, develops, and commercializes drugs for the treatment of viral infections. The company develops Monkeypox Treatment for Monkeypox virus; Adenovirus 71 Treatment for severe pediatric hepatitis caused by Adenovirus 71 or related viruses; and HerpeCide Program Expansion Drug project that develops broad-spectrum nanoviricide drugs against different herpes viruses for different indications. The company also develops FluCide Broad-Spectrum Anti-Influenza nanoviricide, which is injectable for hospitalized patients and oral for outpatients; Nanoviricide eye drops for viral diseases of the external eye; DengueCide for treatment of various types of Dengue viruses; and HIVCide, an escape-resistant anti-HIV nanoviricide. In addition, it develops other nanoviricides drug projects for treatment of different viruses and indications; and HerpeCide program expansion drug projects for different herpes viruses for different indications. The company was founded in 2005 and is based in Shelton, Connecticut.

Dividend Payments

Forward Yield
Forward Payment

Trailing Yield
Trailing Payment

Last Increase
> 10 Years Ago
Last Cut
> 10 Years Ago

5 Year Average Yield
Vs Current Yield

5 Year Div Growth Rate
Payment Frequency

Historical Dividend Payments